This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
2024 Medicare Outcomes 
DAIC
JANUARY 22, 2024
By not including a fix to the 3.37% cut to the Medicare Physician Fee Schedule in the most recent continuing resolution, practices around the country are left in a state of uncertainty for their own futures, as well as patient access to care,” said American College of Cardiology President B. Hadley Wilson , MD, FACC.
105 
DAIC
JANUARY 29, 2024
milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio. The analysis included 4,798 patients from 207 STS sites who underwent esophagectomy between 2012-2019.
111 
CardiacWire
MARCH 24, 2024
Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.
59 
DAIC
DECEMBER 5, 2024
tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. As we’ve seen with their recent Medicare and CPT I code approvals, this technology is both valuable and ready today in the fight against heart disease.”
DAIC
MAY 2, 2024
Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. , The CardiAMP cell therapy trials for the indications of both chronic myocardial ischemia and ischemic heart failure are covered by the Center for Medicare and Medicaid for both treatment and control procedures.
95 
DAIC
APRIL 24, 2024
milla1cf Wed, 04/24/2024 - 19:01 April 24, 2024 — Hello Heart , a digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a growing senior population. Yet, CVD remains the leading cause of death in the U.S.,
116 
DAIC
MARCH 28, 2025
vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2024,November 8).
59 
DAIC
MARCH 13, 2024
Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Across all patients there was a reduction in cardiac death equivalents and major adverse cardiac and cerebrovascular events. said Peter Altman , PhD.,
111 
DAIC
MARCH 27, 2025
In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. Dorbala, S., Di Carli,M. Bateman, T.
DAIC
FEBRUARY 14, 2024
milla1cf Wed, 02/14/2024 - 18:53 February 14, 2024 — The American College of Cardiology ’s newest registry offers data-driven insights on cardiac procedures performed in the ambulatory surgery setting through its first-of-its-kind dashboard.
105 
The American Journal of Cardiology
OCTOBER 23, 2024
Publication date: Available online 22 October 2024 Source: The American Journal of Cardiology Author(s): Nathan W. Kong, Joseph M. Kim, Anna K. Krawisz, Patrick Heindel, Archana Tale, Yang Song, Jeffrey L. Weinstein, Mohamad A. Hussain, Eric A.
DAIC
JANUARY 12, 2024
milla1cf Fri, 01/12/2024 - 13:23 January 12, 2024 — BridgeBio Pharma, Inc. , Findings presented in the NEJM support acoramidis as an effective and safe treatment option for patients with ATTR-CM and reinforce the hypothesis that greater stabilization of TTR may be associated with improved clinical outcomes. in the U.S.
105 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP60-AWMP60, February 1, 2024. Methods:We analyzed data on Medicare fee-for-service beneficiaries aged ≥65 years hospitalized with AIS from April 1, 2020, to December 31, 2021. Introduction:Extensive evidence shows that social inequities create health disparities. 0.66, high 0.67-1.0).Results:Among
40 
GEMMS
MARCH 7, 2024
In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. Be sure to check your qualifying status using the QPP Participation Status Tool.
52 
DAIC
MARCH 20, 2024
milla1cf Wed, 03/20/2024 - 18:50 March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). For more information: www.biotronik.com References: 1 Kwong M.,
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP109-AWP109, February 1, 2024. Methods:Data were retrieved from a CMS Qualified Entity housing healthcare utilization data for ≥80% of the Texas state population (100% of Medicare Fee-for-Service). and 82.3% (Panel D).Conclusion:Post
40 
DAIC
MARCH 31, 2025
10 , 11 , 12 , 13 As healthcare systems increasingly adopt value-based care models, extending monitoring beyond 48 hours can improve patient outcomes, reduce missed diagnoses, and help contain healthcare resource utilization. Accessed April 25, 2024. iRhythm Technologies, 2024. Published March 24, 2022. link] 5 Ataklte et al.
52 
DAIC
JUNE 4, 2024
To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period. Stroke recovery is a challenging process that extends for months after hospital discharge. This missing puzzle piece matters now more than ever.
115 
DAIC
MARCH 7, 2024
The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. We thank the FDA for its speedy review and approval of the important follow-on Phase III trial.
105 
GEMMS
APRIL 8, 2024
Below, we will explore the 2024 changes to MIPS and how interoperability features in EHR software can revolutionize how cardiology providers approach MIPS reporting changes. Additionally, the 2024 final rule retains the methodology for measuring scores and achieving points with no notable alterations. What is MIPS?
52 
DAIC
MAY 16, 2024
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
All About Cardiovascular System and Disorders
APRIL 19, 2024
A potentially serious drug interaction between diltiazem and apixaban or rivaroxaban has been reported in US Medicare patients taking these drugs together for atrial fibrillation. It was a retrospective cohort study which included US Medicare benefiaries aged 65 years or more with atrial fibrillation and follow up period was one year.
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP105-AWP105, February 1, 2024. Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery. Participants (n=50) were facilitated by a clinical navigator (OT or LCSW).
40 
DAIC
JUNE 12, 2024
Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.” Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries. J Vasc Surg Venous Lymphat Disord. 2017;5:678-687. [5]
105 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP246-AWP246, February 1, 2024. Outcomes included health-related quality of life (HRQoL) at 90-180 days post-stroke/TIA; and all-cause mortality and hospital readmissions (all-cause, cardiovascular disease) within 1 year post-stroke/TIA. high risk; interquartile range 3-6).
40 
DAIC
JULY 25, 2024
mtaschetta-millane Thu, 07/25/2024 - 09:08 July 25, 2024 — BioCardia, Inc. , The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures.
111 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A5-A5, February 1, 2024. As of 2023, Center for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable. Medicare and Mount Sinai Health System registry data were linked using a matching algorithm. of Medicare cases even though it was documented in 93.1%
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142159-A4142159, November 12, 2024. While TR can worsen the clinical outcomes in HF patients, its impact on gender, racial and socioeconomic factors remains largely unexplored.
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP118-ATP118, February 1, 2024. Background:It is well documented that rehabilitation post-stroke is associated with better functional outcomes, however, in the United States access to post-acute care rehabilitation is becoming increasingly limited.
40 
DAIC
APRIL 23, 2024
milla1cf Tue, 04/23/2024 - 16:03 April 23, 2024 — CDL Nuclear Technologies , a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. For more information: cdl-mobile-trailers-7.webflow.io webflow.io
52 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A14-A14, February 1, 2024. Methods:We conducted a national cross-sectional analysis of 71,078,619 adults aged >65 years enrolled in Medicare from January 1, 2016 to December 31, 2019. mean 0.818, SD 2.874, IQR 3.02). 1.25, p<0.0001).
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP51-AWMP51, February 1, 2024. Background:Medical comorbidities and stroke risk factors explain only a proportion of stroke incidence and outcomes in different populations. The primary outcome measure was discharge to home.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP48-AWP48, February 1, 2024. Participating Get With The Guidelines® (GWTG)-Stroke hospitals track EBG data to improve outcomes. Payer sources were identified as: self-pay, Medicaid, Medicare, and Private/HMO. Differences in compliance rates were 10% for Medicare, 13.5%
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP106-AWMP106, February 1, 2024. Background:Medical comorbidities and stroke risk factors only explain a proportion of stroke incidence and outcomes in different populations. Our findings can be used to develop interventions that reduce inequity in ischemic stroke outcomes at discharge.
40 
DAIC
JANUARY 3, 2024
milla1cf Wed, 01/03/2024 - 11:45 January 3, 2024 — HeartFlow, Inc. , With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes.
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP261-AWP261, February 1, 2024. Objective:Physician adherence to evidence-based clinical guidelines improves outcomes in acute ischemic stroke (AIS) and transient ischemic attack (TIA) patients.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATMP19-ATMP19, February 1, 2024. Background:Stroke is a leading cause of chronic disability, with neuropsychiatric presentations being increasingly recognized as complications that hinder rehabilitation and patient outcomes. 95%CI (0.2,0.9). 95%CI (0.4,0.9) 95% CI (1.1,7.7)
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATMP15-ATMP15, February 1, 2024. Large vessel occlusion (LVO), a quarter of ischemic strokes, portends poor outcomes. They were more likely insured by Medicare, less by Medicaid, and less likely baseline ambulatory, have a Bachelor’s degree, or own a home, with lower median income.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. vs. 83.8%), and covered by Medicare (91.7% Both groups (PBS vs. no PBS) were predominantly female (59.7% vs. 73.7%), identified as white (76.5% vs. 90.7%). Despite being the most prevalent comorbidity, hypertension (83.6% vs. 36.4%), prior myocardial infarction (12.8%
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4141439-A4141439, November 12, 2024. The outcome follow-up began after the 6-month period. Background:Catheter ablation (CA) is increasingly used for treatment of atrial fibrillation (AF). However, CA has not been widely adopted in the older population with AF.
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
52 
Stroke Journal
JANUARY 30, 2025
In spite of these advances, stroke outcomes continue to be reliant on factors only attributable to the patient. Methods:All patients entered into the GWTG-Stroke registry for NYC Health+Hospitals/Kings County between 3/1/2022 and 3/31/2024. 3.06, p<0.04). 3.82, p<0.01). 1.04, p<0.02) and payment source (1.79, 1.01-3.16,
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP286-AWP286, February 1, 2024. The primary outcome was seizure, defined using previously validated ICD-10-CM code G40.x, Conclusions:In a nationally representative cohort of Medicare beneficiaries, CAA was associated with an increased risk of seizures.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP96-AWP96, February 1, 2024. Introduction:Timely administration of thrombolytic therapy remains the cornerstone of ischemic stroke management and is associated with better functional outcomes. p < 0.0001), and those with Medicare/Medicaid have a decrease in time of 1291.83min (1652.1-931.5,
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content